Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Selby

Showing results (201-210 of 316) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Psycho-Oncology|March 26, 2010
Discussion of emotional and social impact of cancer during outpatient oncology consultationsSally Taylor, Clare Harley, Lyndsay J Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
British Journal of Haematology|January 13, 2009
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenSylvia Feyler, Marie von Lilienfeld-Toal, Sarah Jarmin, et al.
Proteomics|April 19, 2011
Shotgun proteomics of human bile in hilar cholangiocarcinomaShahid G Farid, Rachel A Craven, Jianhe Peng, et al.
British Journal of Cancer|November 11, 2010
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive proteinS P K Jagdev, W Gregory, N S Vasudev, et al.
Annals of Clinical Biochemistry|November 1, 1996
Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancerT Bertsch, R E Banks, M A Forbes, et al.
Hybridoma|August 1, 1997
Production and characterization of monoclonal antibodies to human interleukin-12R W Carter, P M Patel, A J Stanley, et al.
Proteomics. Clinical Applications|August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal diseaseDouglas Thompson, Willem Develter, David A Cairns, et al.
The American Journal of Cardiology|June 17, 2000
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)S M Haffner, R D Agostino, M F Saad, et al.
Pageof 32

Showing results (201-210 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Psycho-Oncology|March 26, 2010
Discussion of emotional and social impact of cancer during outpatient oncology consultationsSally Taylor, Clare Harley, Lyndsay J Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
British Journal of Haematology|January 13, 2009
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenSylvia Feyler, Marie von Lilienfeld-Toal, Sarah Jarmin, et al.
Proteomics|April 19, 2011
Shotgun proteomics of human bile in hilar cholangiocarcinomaShahid G Farid, Rachel A Craven, Jianhe Peng, et al.
British Journal of Cancer|November 11, 2010
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive proteinS P K Jagdev, W Gregory, N S Vasudev, et al.
Annals of Clinical Biochemistry|November 1, 1996
Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancerT Bertsch, R E Banks, M A Forbes, et al.
Hybridoma|August 1, 1997
Production and characterization of monoclonal antibodies to human interleukin-12R W Carter, P M Patel, A J Stanley, et al.
Proteomics. Clinical Applications|August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal diseaseDouglas Thompson, Willem Develter, David A Cairns, et al.
The American Journal of Cardiology|June 17, 2000
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)S M Haffner, R D Agostino, M F Saad, et al.
Pageof 32